MarginsXMarginsX
Home › Markets › Health Care › MDT

Medtronic plc. (MDT)

MDT trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$102.88
+0.02% on the day
Market cap
$131.6B
Large cap
Revenue · 2026
$36.4B
+8.4% on 2025
Net income · 2026
$4.8B
13.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-04-24, https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-04-24.

Profile

FieldValue
TickerMDT on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001613103
SEC industry codeElectromedical & Electrotherapeutic Apparatus

Financials · 2026

LineValue
Revenue$36.4B
Net income$4.8B
Operating income$6.5B
Net margin13.2%
Operating margin17.8%
Revenue growth+8.4%
Cash$1.9B
Total assets$93.0B
P/E (computed)27.4×
P/S (computed)3.6×

Warning signs

Cash runway
Cash-flow positive
$1.7B cash at July 31, 2026
Share count, 1 year
-0.3%
2025-08-20 to 2026-08-28 · -3.9% over 3 years
Going-concern doubt
No
10-Q filed September 3, 2026
Insider net buying, 12 months
-$8.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-09-03
Cash and burn$1.7B cash; operating cash flow $2.0B a quarter.Report 2026-07-31
Shares outstanding1,279,137,890 (2026-08-28); 1,282,685,882 a year earlier; 1,330,533,713 three years earlier.Cover page 2026-08-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-10-15
AuditorPricewaterhouseCoopers LLP, Minneapolis, Minnesota, United StatesPCAOB Form AP 2026-07-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $8.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-07-31
$9.8B$1.5B$1.8B$1.7B$28.2B$37.5B10-Q 2026-09-03
Q4 2026
2026-04-24
$9.8B$1.2B$2.6B$1.9B$28.0B$36.4B10-K 2026-06-18
Q3 2026
2026-01-23
$9.0B$1.1B$2.7B$1.1B$28.1B$35.5B10-Q 2026-02-24
Q2 2026
2025-10-24
$9.0B$1.4B$925.0M$1.3B$29.1B$34.8B10-Q 2025-11-25
Q1 2026
2025-07-25
$8.6B$1.0B$1.1B$1.3B$28.6B$34.2B10-Q 2026-09-03
Q4 2025
2025-04-25
$8.9B$1.1B$2.5B$2.2B$28.5B$33.5B10-K 2026-06-18
Q3 2025
2025-01-24
$8.3B$1.3B$2.6B$1.2B$26.6B$33.2B10-Q 2026-02-24
Q2 2025
2024-10-25
$8.4B$1.3B$958.0M$1.4B$28.3B$33.0B10-Q 2025-11-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-03-09
Latest annual report10-K2026-06-18
Latest quarterly / interim10-Q2026-09-03
Latest current report8-K2026-10-19
Latest proxyDEFA14A2026-08-17

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.0%
1 month+10.6%
3 months+13.6%
Year to date+7.1%
1 year+7.0%
From 52-week high-2.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
LIVNLivaNova PLC$92.44+1.23%$5.1B
AXGNAxogen Inc.$55.38-0.98%$3.3B
TMDXTransMedics Group Inc.$92.21+0.91%$3.2B
CNMDCONMED Corporation$49.35-2.45%$1.5B
CBLLCeriBell Inc.$26.42+1.07%$1.0B
INMDInMode Ltd.$13.15-0.90%$755.9M
CVCapsoVision Inc.$6.47+7.30%$346.9M
ELMDElectromed Inc.$23.10-5.02%$188.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier